Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Jessica Reynolds is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Thrombo-Inflammation Drives Venous Thromboembolism (VTE) in Patients with HIV (PWH) on Anti-Retroviral Therapy (ART)
Reynolds, J. (PI) & Mahajan, S. (CoI)
01/1/25 → 01/1/28
Project: Research
-
Initiative for Maximizing Student Development at University at Buffalo
Dubocovich, M. (PI), Liu, X. (CoI), O'Donnell, J. (CoI), Reynolds, J. (CoI), Wichlacz, S. (CoI), Sodano, S. (CoI) & Sprowl, J. (CoI)
National Institute of General Medical Sciences
02/1/22 → 01/31/27
Project: Research
-
Immunomodulatory Therapy After Resuscitation From Cardiac Arrest
Weil, B. (PI), Reynolds, J. (CoI) & Poulsen, D. (CoI)
National Heart Lung and Blood Institute
01/1/22 → 12/31/26
Project: Research
-
Immunotherapeutic nanoparticles: Implications for the treatment of tuberculosis and HIV
Reynolds, J. (PI) & Kutscher, H. (CoI)
National Institute of Allergy & Infectious Disease
08/2/23 → 07/31/25
Project: Research
-
Repeated pulmonary dosing of β-glucan-chitosan-PLGA nanoparticles controls Mycobacterium tuberculosis in mice
Kutscher, H. L., Tamblin, M., Smith, E., Shah, A., Kenney, P. O. & Reynolds, J. L., Feb 2026, In: Antimicrobial Agents and Chemotherapy. 70, 2Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of Mycobacterium tuberculosis in BALB/c mice
Kutscher, H. L., Tamblin, M., Kenney, P. & Reynolds, J. L., Jun 2026, In: Antimicrobial Agents and Chemotherapy. 70, 6, e00281-26.Research output: Contribution to journal › Article › peer-review
Open Access -
Determining the minimum inhibitory concentrations of pyrazinamide against Mycobacterium tuberculosis clinical isolates at a neutral pH of 6.8 using the broth microdilution method
Tamblin, M., Shi, W., Chen, L. & Reynolds, J., 2025, In: Frontiers in Microbiology. 16, 1688772.Research output: Contribution to journal › Article › peer-review
Open Access -
Inhalational Delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid Nanoparticles Enhance Alveolar Macrophage Rifampin Concentrations for the Treatment of Tuberculosis
Kutscher, H. L., Tamblin, M., Karki, S., Chaves, L., Baird, M., Parvin, A., Smith, E., Dube, A., Zhang, Z., Chakraborty, S., Kenney, P. & Reynolds, J. L., Apr 2025, In: Advanced Therapeutics. 8, 4, 2400057.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Omics analysis reveals galectin-3 to be a potential key regulator of allergic inflammation in hereditary angioedema
Mahajan, S. D., Aalinkeel, R., Reynolds, J. L., Machhar, J. S., Ghebrehiwet, B. & Schwartz, S. A., Feb 2025, In: Journal of Allergy and Clinical Immunology: Global. 4, 1, 100353.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations